Brief: Glaukos Q3 Sales USD 78 Million Vs. IBES Estimate USD 75.3 Million
Nov 01 (Reuters) - Glaukos Q3 adjusted net income USD -24.2 million. * Q3 net income USD -30.4 million * Q3 adjusted gross margin 83% * Q3 gross margin 76% * outlook FY sales USD 307-310 million
Recent news on Glaukos
See all newsGlaukos says late-stage eye disease treatment shows lasting benefits after single dose
Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
US RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary